Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | Patent Publication Number 20200199211

US 20200199211 A1
Patent NumberUS 10703809 B1
Application Number16804567
Filled DateFeb 28, 2020
Priority DateMar 15, 2007
Publication DateJun 25, 2020
Original AssigneeAstrazeneca
Current AssigneeAlexion Pharmaceuticals
Inventor/ApplicantsLeonard Bell
Mark J. Evans
Russell P. ROTHER
Mark J. EVANS
Leonard BELL
Russell P. Rother
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.